IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,487,221 | -25.3% | 236,543 | -38.9% | 0.02% | -30.0% |
| Q1 2023 | $6,007,287 | +64.4% | 387,317 | +88.2% | 0.03% | +50.0% |
| Q4 2022 | $3,653,554 | +137.7% | 205,834 | +14.1% | 0.02% | +150.0% |
| Q4 2021 | $1,537,000 | -51.7% | 180,395 | -50.7% | 0.01% | -60.0% |
| Q3 2021 | $3,179,000 | -18.4% | 365,793 | -0.8% | 0.02% | -25.9% |
| Q2 2021 | $3,897,000 | -43.5% | 368,729 | -14.3% | 0.03% | -46.0% |
| Q1 2021 | $6,897,000 | – | 430,015 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,717,182 | $139,213,000 | 3.92% |
| Ghost Tree Capital, LLC | 525,000 | $12,784,000 | 3.37% |
| Logos Global Management LP | 625,000 | $15,219,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 350,000 | $8,523,000 | 2.46% |
| BVF INC/IL | 1,088,479 | $26,504,000 | 1.63% |
| Vivo Capital, LLC | 800,000 | $19,480,000 | 1.40% |
| Camber Capital Management LP | 800,000 | $19,480,000 | 1.12% |
| Sio Capital Management, LLC | 152,450 | $3,712,000 | 1.08% |
| Prosight Management, LP | 95,500 | $2,325,000 | 1.00% |
| Parkman Healthcare Partners LLC | 125,125 | $3,047,000 | 0.86% |